tetrahydrocurcumin has been researched along with Angiogenesis, Pathologic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhattarakosol, O; Changtam, C; Patumraj, S; Yoysungnoen, B | 1 |
Bhattarakosol, P; Changtam, C; Patumraj, S; Yoysungnoen, B | 1 |
Kuttan, G; Leyon, PV | 1 |
3 other study(ies) available for tetrahydrocurcumin and Angiogenesis, Pathologic
Article | Year |
---|---|
Combinational Treatment Effect of Tetrahydrocurcumin and Celecoxib on Cervical Cancer Cell-Induced Tumor Growth and Tumor Angiogenesis in Nude Mice.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Celecoxib; Combined Modality Therapy; Curcumin; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Female; Mice; Mice, Nude; Neovascularization, Pathologic; Sulfonamides; Uterine Cervical Neoplasms | 2016 |
Effects of tetrahydrocurcumin on hypoxia-inducible factor-1α and vascular endothelial growth factor expression in cervical cancer cell-induced angiogenesis in nude mice.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Curcumin; Down-Regulation; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumour specific angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Capillaries; Curcumin; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Nitric Oxide; Phytotherapy; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2003 |